Aligos Therapeutics, Inc. SEC filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Aligos Therapeutics, Inc. | 2026-05-07 | 0001193125-26-212001 |
| 10-K | Aligos Therapeutics, Inc. | 2026-03-05 | 0001193125-26-092614 |
| 10-Q | Aligos Therapeutics, Inc. | 2025-11-06 | 0001193125-25-268203 |
| 10-Q | Aligos Therapeutics, Inc. | 2025-08-06 | 0000950170-25-104042 |